发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 268 |
| England | 83 |
| CHINA MAINLAND | 60 |
| GERMANY (FED REP GER) | 39 |
| Switzerland | 37 |
| Belgium | 33 |
| Canada | 28 |
| Netherlands | 28 |
| India | 23 |
| France | 22 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| ROCHE HOLDING | 41 |
| GLAXOSMITHKLINE | 38 |
| ASTRAZENECA | 34 |
| BRISTOL-MYERS SQUIBB | 34 |
| MERCK & COMPANY | 27 |
| COVANCE | 26 |
| PFIZER | 26 |
| PRA HLTH SCI | 25 |
| JOHNSON & JOHNSON | 21 |
| NOVARTIS | 15 |
文章引用情况
1
Very complex internal standard response variation in LC-MS/MS bioanalysis: root cause analysis and impact assessment2
Quantification of phenolic acid metabolites in humans by LC-MS: a structural and targeted metabolomics approach3
Synthetic cannabinoids in biological specimens: a review of current analytical methods and sample preparation techniques4
Immunogenicity of therapeutic protein products: current considerations for anti-drug antibody assay in Japan5
Drug exposure during pregnancy: analytical methods and toxicological findings6
Surface plasmon resonance as a tool for ligand-binding assay reagent characterization in bioanalysis of biotherapeutics7
Immunogenicity of antibody-drug conjugates: observations across 8 molecules in 11 clinical trials8
Effective presentation of immunogenicity risk assessments and related data in regulatory dossiers9
A novel HPLC-DAD method for simultaneous determination of febuxostat and diclofenac in biological samples: pharmacokinetic outcomes10
Sensitive and robust LC-MS/MS analysis of digoxin in human plasma through optimization of in-source adduct formation